Additional file 11: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion

Analysis of the The Cancer Genome Atlas (TCGA) data showed differentially expressed genes in BCL9-high versus BCl9-low tumors. Differential gene expression was performed between TCGA breast cancer samples with a normal range of BCL9 and samples with upregulated BCL9. A list of significant genes (1,756 down regulated 980 upregulated) was obtained with a threshold of a false discovery rate ≥0.05 and log fold change 0.26. (XLSX 1492 kb)